Dr. Ding Wang
Claim this profileHenry Ford Hospital
About Ding Wang
Education:
- Holds an MD (Doctor of Medicine).
- Earned a PhD (Doctor of Philosophy).
Experience:
- Serves as the Medical Director of the Clinical Trials Office at Henry Ford Health System.
- Principal Investigator for over 150 clinical trials.
- Manages a team of clinical research professionals and ensures compliance with regulatory standards.
- Provides administrative and financial oversight for approximately 170 clinical research projects.
- Facilitates staff certification in Good Clinical Practice and Human Subject's Protection.
Area of expertise
Lung Cancer
Ding Wang has run 14 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Ding Wang has run 9 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Henry Ford Hospital
Henry Ford Macomb Hospital-Clinton Township
Clinical Trials Ding Wang is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
More about Ding Wang
Clinical Trial Related
7 years of experience running clinical trials · Led 47 trials as a Principal Investigator · 13 Active Clinical Trials
Treatments Ding Wang has experience with
- Nivolumab
- Pembrolizumab
- Cisplatin
- Carboplatin
- Gemcitabine Hydrochloride
- Ipilimumab
Breakdown of trials Ding Wang has run
Lung Cancer
Cancer
Pancreatic Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ding Wang specialize in?
Ding Wang focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ding Wang currently recruiting for clinical trials?
Yes, Ding Wang is currently recruiting for 13 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Ding Wang has studied deeply?
Yes, Ding Wang has studied treatments such as Nivolumab, Pembrolizumab, Cisplatin.
What is the best way to schedule an appointment with Ding Wang?
Apply for one of the trials that Ding Wang is conducting.
What is the office address of Ding Wang?
The office of Ding Wang is located at: Henry Ford Hospital, Detroit, Michigan 48202 United States. This is the address for their practice at the Henry Ford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.